Javascript must be enabled to continue!
BugSigDB: A Comprehensive Database of Published Microbial Signatures for Epidemiological Analysis of Microbiome Data
View through CrossRef
Most microbiome studies report “signatures” of differentially abundant microbial taxa for a disease or exposure of interest, but heterogeneity in how complex methods and results are reported make comparisons between studies difficult. A signature represents statistically different bacterial taxa identified in a given study and represents a summary of a study’s findings. These signatures can be assessed across studies for consistency and agreement. BugSigDB is a manually curated database of microbial signatures collected from published microbiome differential abundance studies. Key information for each study is curated including study design, sample size, participant information, laboratory methods, and statistical methods in a structured, standardized format. BugSigDB is open source and available for researchers to use and contribute to. As of January 11th, 2022 it contains 2,107 microbial signatures curated from 522 published microbiome research articles. We present an applied example of use of BugSigDB gut microbiome signatures for COVID-19. Analysis of 132 signatures from 32 studies of COVID-19 and the gut microbiome reveal significant co-occurrence of several bacterial taxa within the phylum Firmicutes along with Actinobacteria, Bacteriodetes, and Proteobacteria (Figure 1). Across these studies, the genera Bacteroides and Alistipes were statistically found to be in decreased abundance among COVID-19 patients. bugsigdbr, an accompanying open source R/Bioconductor package, provides signatures and accompanying data downloads in a tidy data format. Data can also be accessed via a semantic wiki web interface at https://bugsigdb.org. Together, they allow for efficient systematic analysis of findings from microbiome studies across a variety of diseases and conditions of interest.
Title: BugSigDB: A Comprehensive Database of Published Microbial Signatures for Epidemiological Analysis of Microbiome Data
Description:
Most microbiome studies report “signatures” of differentially abundant microbial taxa for a disease or exposure of interest, but heterogeneity in how complex methods and results are reported make comparisons between studies difficult.
A signature represents statistically different bacterial taxa identified in a given study and represents a summary of a study’s findings.
These signatures can be assessed across studies for consistency and agreement.
BugSigDB is a manually curated database of microbial signatures collected from published microbiome differential abundance studies.
Key information for each study is curated including study design, sample size, participant information, laboratory methods, and statistical methods in a structured, standardized format.
BugSigDB is open source and available for researchers to use and contribute to.
As of January 11th, 2022 it contains 2,107 microbial signatures curated from 522 published microbiome research articles.
We present an applied example of use of BugSigDB gut microbiome signatures for COVID-19.
Analysis of 132 signatures from 32 studies of COVID-19 and the gut microbiome reveal significant co-occurrence of several bacterial taxa within the phylum Firmicutes along with Actinobacteria, Bacteriodetes, and Proteobacteria (Figure 1).
Across these studies, the genera Bacteroides and Alistipes were statistically found to be in decreased abundance among COVID-19 patients.
bugsigdbr, an accompanying open source R/Bioconductor package, provides signatures and accompanying data downloads in a tidy data format.
Data can also be accessed via a semantic wiki web interface at https://bugsigdb.
org.
Together, they allow for efficient systematic analysis of findings from microbiome studies across a variety of diseases and conditions of interest.
Related Results
African microbiome data in BugSigDB
African microbiome data in BugSigDB
The complexity and diversity in microbiome research pose difficulties in consolidating and evaluating existing knowledge. BugSigDB, an open-source and open-science platform (https:...
Impact of urbanization on gut microbiome mosaics across geographic and dietary contexts
Impact of urbanization on gut microbiome mosaics across geographic and dietary contexts
ABSTRACT
This study provides a comprehensive assessment of how urban-rural divides influence gut microbial diversity and composit...
The Future of Microbiome Medicine – An Editor’s Perspective
The Future of Microbiome Medicine – An Editor’s Perspective
The microbiome field continues to grow at an exponential rate with sophisticated approaches that are pushing the frontiers of science and translating fast into clinical practice. T...
Human oral microbiome as forensic biomarkers for individual identification: A systematic review
Human oral microbiome as forensic biomarkers for individual identification: A systematic review
: The oral microbiome is a promising and novel source of biomarkers for forensic identification. It offers distinct signatures that may differentiate individuals, sparking new aven...
Quantifying the impact of Human Leukocyte Antigen on the human gut microbiome
Quantifying the impact of Human Leukocyte Antigen on the human gut microbiome
AbstractObjectiveThe gut microbiome is affected by a number of factors, including the innate and adaptive immune system. The major histocompatibility complex (MHC), or the human le...
Learning a deep language model for microbiomes: the power of large scale unlabeled microbiome data
Learning a deep language model for microbiomes: the power of large scale unlabeled microbiome data
Abstract
We use open source human gut microbiome data to learn a microbial “language” model by adapting techniques from Natural Language Processing (NLP). Our micro...
The Regional Diversity of Gut Microbiome Along the GI Tract
The Regional Diversity of Gut Microbiome Along the GI Tract
Abstract
Background: The proliferation and survival of microbial organisms including intestinal microbes are determined by their surrounding environments. Contrary to popul...
Profiling the microbiome in breast cancer patients before and after treatment with cannabis oil
Profiling the microbiome in breast cancer patients before and after treatment with cannabis oil
With long-term cancer treatment, female breast cancer patients encounter debilitating side effects from a current range of cancer therapies. Cannabinoids (CBs) have been widely use...

